Northwestern Mutual Wealth Management Co. Purchases 14,895,480 Shares of Avanos Medical, Inc. $AVNS

Northwestern Mutual Wealth Management Co. lifted its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 1,596,514.5% during the fourth quarter, Holdings Channel reports. The firm owned 14,896,413 shares of the company’s stock after acquiring an additional 14,895,480 shares during the period. Northwestern Mutual Wealth Management Co. owned approximately 0.32% of Avanos Medical worth $167,287,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in AVNS. Versant Capital Management Inc lifted its position in shares of Avanos Medical by 49.7% during the third quarter. Versant Capital Management Inc now owns 2,692 shares of the company’s stock valued at $31,000 after purchasing an additional 894 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of Avanos Medical by 969.3% during the second quarter. Russell Investments Group Ltd. now owns 2,545 shares of the company’s stock valued at $31,000 after purchasing an additional 2,307 shares in the last quarter. Wexford Capital LP bought a new position in shares of Avanos Medical during the third quarter valued at about $70,000. Tower Research Capital LLC TRC lifted its position in shares of Avanos Medical by 433.0% during the second quarter. Tower Research Capital LLC TRC now owns 6,257 shares of the company’s stock valued at $77,000 after purchasing an additional 5,083 shares in the last quarter. Finally, Quantessence Capital LLC bought a new position in shares of Avanos Medical during the third quarter valued at about $116,000. 95.17% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on AVNS. Wall Street Zen lowered shares of Avanos Medical from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Zacks Research lowered shares of Avanos Medical from a “hold” rating to a “strong sell” rating in a research report on Thursday, May 7th. Finally, Weiss Ratings raised shares of Avanos Medical from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, April 22nd. Two investment analysts have rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

Avanos Medical Trading Up 0.1%

NYSE:AVNS opened at $24.73 on Friday. The company has a current ratio of 2.48, a quick ratio of 1.40 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $1.16 billion, a PE ratio of -15.36 and a beta of 1.58. The firm’s 50 day moving average is $18.53 and its 200 day moving average is $14.55. Avanos Medical, Inc. has a 12 month low of $9.30 and a 12 month high of $24.91.

Avanos Medical (NYSE:AVNS) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.06. Avanos Medical had a positive return on equity of 5.39% and a negative net margin of 10.39%.The business had revenue of $182.20 million during the quarter, compared to analyst estimates of $170.00 million. During the same period in the prior year, the company earned $0.26 earnings per share. Avanos Medical’s revenue was up 8.8% compared to the same quarter last year. Sell-side analysts expect that Avanos Medical, Inc. will post 1.07 earnings per share for the current year.

Avanos Medical Profile

Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.

In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.